Connected Care of West Tennessee Public Reporting

AOC Name and Location

ACO of Central Alabama 1, LLC (d/b/a) Connected Care of West Tennessee
3401 West End Avenue, Suite 290
Nashville, Tennessee 37203

Primary Contact

Katie Herron
(615) 875-0834
katie.herron@vhan.com

Participants

No participants are involved in a joint venture between ACO professionals and hospitals.

  • West Tennessee Medical Group, Inc
  • Martin Health
  • West Tennessee Medical Associates
  • West Tennessee University Medical Associates, INC
  • West Tennessee Regional medical Associates

Governing Body

  • King, Jim, MD - Board Chair, West Tennessee Medical Group, Inc - ACO Participant Representative, Voting Power: 12.5%
  • Powell, Cynthia, MD - Board President, Vanderbilt University Medical Center - ACO Participant Representative, Voting Power: 12.5%
  • Bryant, Michael, MD - Board Member, Martin Health - ACO Participant Representative, Voting Power: 12.5%
  • Guthrie, David, MD - Board Member, West Tennessee Medical Group, Inc - ACO Participant Representative, Voting Power: 12.5%
  • Rager, Neal - Board Member, West Tennessee Medical Group, Inc - ACO Participant Representative, Voting Power: 12.5%
  • Ravinder, Machra, MD - Board Member, West Tennessee Medical Associates - ACO Participant Representative, Voting Power: 12.5%
  • Baker, John, MD - Board Member, West Tennessee Medical Associates - ACO Participant Representative, Voting Power: 12.5%
  • Hill, Ronald - Board Member, Medicare Beneficiary Representative - Voting Power: 12.5%

Clinical and Administrative Leadership

  • Cynthia Powell, MD, ACO Executive Director & Medical Director
  • Kimberly Wilson, Compliance Officer
  • Pam Bruce, DNP, MSN, RN, Quality Assurance/Improvement Officer

Committees and Committee Leadership

Performance Improvement Committee
Committee Leader: Jim King, MD - Medical Director

Types of ACO participants, or combinations of participants, that formed the ACO:

  • Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses
  • Second Agreement Period

    • Performance Year 2026, N/A

      Performance Year 2025, N/A

      Performance Year 2024, $0

    • Performance Year 2023, $753,089.34
    • Performance Year 2022, $0
  • First Agreement Period
    • Performance Year 2021, $2,007,009
    • Performance Year 2020, $0
    • Performance Year 2019, $0
    • Performance Year 2018, $0
Shared Savings Distribution

Second Agreement Period

  • Performance Year 2026
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2025
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2024
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2023
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 40%
    • Proportion of distribution to ACO participants: 50%
  • Performance Year 2022
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A

First Agreement Period

  • Performance Year 2021
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 40%
    • Proportion of distribution to ACO participants: 50%
  • Performance Year 2020
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2019
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2018
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A

Quality Performance Results

2024 Quality Performance Results:

*For Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) [Quality ID #001], Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Eligible Clinician Groups [Measure #479], and Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], a lower performance rate indicates better measure performance. 

*For Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], patients are excluded if they were attributed to Qualifying Alternative Payment Model (APM) Participants (QPs). Most providers participating in Track E and ENHANCED track ACOs are QPs, and so performance rates for Track E and ENHANCED track ACOs may not be representative of the care provided by these ACOs' providers overall. Additionally, many of these ACOs do not have a performance rate calculated due to not meeting the minimum of 18 beneficiaries attributed to non-QP providers.

For previous years' financial and quality performance results, please visit data.cms.gov

Payment Rule Waivers 

  •  Skilled Nursing Facility (SNF) 3-day Rule Waiver:

    • Our ACO uses the SNF 3-day Rule Waiver, pursuant to 42 CFR 425.612